サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1546141

血管ステントの世界市場

Vascular Stents

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
血管ステントの世界市場
出版日: 2024年09月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管ステントの世界市場は2030年までに133億米ドルに達する見込み

2023年に100億米ドルと推定される血管ステントの世界市場は、2023年から2030年にかけてCAGR 4.2%で成長し、2030年には133億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるバルーン拡張型ステントは、CAGR 4.9%を記録し、分析期間終了までに92億米ドルに達すると予測されます。自己拡張型ステントセグメントの成長率は、分析期間中CAGR 2.9%と推定されます。

米国市場は27億米ドル、中国はCAGR 7.8％で成長すると予測

米国の血管ステント市場は2023年に27億米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 7.8%で推移し、2030年までに30億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.3%と4.5%と予測されています。欧州では、ドイツがCAGR 1.6%で成長すると予測されています。

世界の血管ステント市場- 主要動向と促進要因のまとめ

なぜ血管ステントが血管疾患の治療に不可欠なのか？

血管ステントは、冠動脈疾患、末梢動脈疾患、動脈瘤など、さまざまな血管疾患の治療の要となっています。これらの器具は、狭くなったり詰まったりした血管を開いて適切な血流を回復させ、心臓発作や脳卒中などの合併症を予防するために使用されます。高齢化、座りっぱなしの生活、肥満や糖尿病の増加などの要因により、血管疾患の発生率が上昇しているため、血管ステントに対する需要が高まっています。医療従事者が患者の予後を改善し、閉塞の再発リスクを低減しようとする中で、先進的なステント技術の採用が加速し、市場を牽引しています。

技術革新は血管ステント市場にどのような影響を与えているか？

技術革新は血管ステント市場に大きな影響を与え、より効果的で安全かつ耐久性の高いデバイスの市場開拓につながっています。再狭窄を予防する薬剤を放出する薬剤溶出ステント（DES）のイントロダクションは、この分野に革命をもたらし、再手術の必要性を減らし、患者の長期予後を改善しました。さらに、生体吸収性ステントが開発され、その機能を果たすと徐々に溶解するようになったことは、永久的なインプラントに伴う長期的な合併症を減少させる上で大きな進歩です。また、コバルトクロム合金や白金クロム合金などの先端材料の使用により、ステントの柔軟性、強度、放射線透過性が改善され、複雑な解剖学的構造においても、より正確な配置と優れた性能を発揮できるようになった。このような技術の進歩は、血管疾患の治療に大きなメリットをもたらすため、血管ステントの普及を後押ししています。

血管ステントの新たな動向は？

血管ステント市場は、その将来を形作るいくつかの新たな動向を目の当たりにしています。重要な動向のひとつは、低侵襲手術への嗜好の高まりで、より小さな切開創から高い精度で送達できるステントへの需要を牽引しています。ステントと併用する薬剤コーティングバルーン（DCB）の増加も動向のひとつで、再狭窄の抑制と患者の予後改善に対する補完的なアプローチを提供しています。また、糖尿病患者や複雑な血管構造を持つ患者など、特定の患者集団に対応したステントの開発にも注目が集まっており、より個別化された治療法の選択肢が増えています。さらに、ベアメタルステントと薬剤溶出ステントのその他の特典を併せ持つハイブリッドステントへの関心の高まりも、長期的な安全性と有効性のバランスを提供するこれらのデバイスの市場進化に影響を与えています。

血管ステント市場の成長を促進する要因とは？

血管ステント市場の成長は、世界の罹患率と死亡率の主な要因である血管疾患の有病率の増加など、いくつかの要因によって牽引されています。また、患者の回復時間、入院期間、ヘルスケアコストを削減する必要性から、低侵襲手技に対する需要が高まっていることも、市場成長の原動力となっています。さらに、薬剤溶出性ステント、生体吸収性ステント、ハイブリッドステントの開発など、ステント技術の絶え間ない進歩により、ヘルスケアプロバイダーが利用できる治療選択肢の幅が広がっています。個々の患者のニーズに合わせた治療の重要性を強調する個別化医療への注目の高まりが、先進ステントの採用をさらに後押ししています。さらに、新興市場における血管ステントの利用可能性の増加が、ヘルスケアインフラの改善と心血管の健康に対する意識の高まりに支えられ、市場の拡大に寄与しています。

調査対象企業の例（注目の26社）

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Endologix, Inc.
  • Jotec GmbH
  • Lombard Medical Technologies, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Translumina GmbH
  • Vascular Concepts Ltd.
  • W.L. Gore & Associates, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15457

Global Vascular Stents Market to Reach US$13.3 Billion by 2030

The global market for Vascular Stents estimated at US$10.0 Billion in the year 2023, is expected to reach US$13.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Balloon-Expandable Stents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in the Self-Expandable Stents segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 7.8% CAGR

The Vascular Stents market in the U.S. is estimated at US$2.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.0 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Vascular Stents Market - Key Trends & Drivers Summarized

Why Are Vascular Stents Crucial in Treating Vascular Diseases?

Vascular stents have become a cornerstone in the treatment of various vascular diseases, including coronary artery disease, peripheral artery disease, and aneurysms. These devices are used to open narrowed or blocked blood vessels, restoring proper blood flow and preventing complications such as heart attacks or strokes. The rising incidence of vascular diseases, driven by factors such as aging populations, sedentary lifestyles, and increasing rates of obesity and diabetes, has led to a growing demand for vascular stents. As medical practitioners seek to improve patient outcomes and reduce the risk of recurrent blockages, the adoption of advanced stent technologies has accelerated, driving the market forward.

How Are Technological Innovations Impacting the Vascular Stents Market?

Technological innovations have significantly impacted the vascular stents market, leading to the development of more effective, safe, and durable devices. The introduction of drug-eluting stents (DES), which release medication to prevent restenosis, has revolutionized the field, reducing the need for repeat procedures and improving long-term patient outcomes. Additionally, the development of bioresorbable stents, which gradually dissolve after fulfilling their function, represents a major advancement in reducing long-term complications associated with permanent implants. The use of advanced materials, such as cobalt-chromium and platinum-chromium alloys, has also improved the flexibility, strength, and radiopacity of stents, allowing for more precise placement and better performance in complex anatomies. These technological advancements are driving the widespread adoption of vascular stents, as they offer significant benefits in the treatment of vascular diseases.

What Are the Emerging Trends in Vascular Stents?

The vascular stents market is witnessing several emerging trends that are shaping its future. One key trend is the growing preference for minimally invasive procedures, which are driving the demand for stents that can be delivered through smaller incisions with greater precision. The rise in the use of drug-coated balloons (DCBs) in combination with stents is another trend, offering a complementary approach to reducing restenosis and improving patient outcomes. The market is also seeing an increased focus on the development of stents for specific patient populations, such as those with diabetes or complex vascular anatomies, leading to more personalized treatment options. Additionally, the growing interest in hybrid stents, which combine the benefits of both bare-metal and drug-eluting stents, is influencing the market's evolution, as these devices offer a balance between long-term safety and efficacy.

What Factors Are Driving the Growth of the Vascular Stents Market?

The growth in the vascular stents market is driven by several factors, including the increasing prevalence of vascular diseases, which are major contributors to global morbidity and mortality. The rising demand for minimally invasive procedures, driven by the need to reduce patient recovery times, hospital stays, and healthcare costs, is also fueling market growth. Additionally, the continuous advancements in stent technology, including the development of drug-eluting, bioresorbable, and hybrid stents, are expanding the range of treatment options available to healthcare providers. The growing focus on personalized medicine, which emphasizes the importance of tailoring treatments to individual patient needs, is further boosting the adoption of advanced stents. Moreover, the increasing availability of vascular stents in emerging markets, supported by improving healthcare infrastructure and rising awareness of cardiovascular health, is contributing to the market's expansion.

Select Competitors (Total 26 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Endologix, Inc.
  • Jotec GmbH
  • Lombard Medical Technologies, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Translumina GmbH
  • Vascular Concepts Ltd.
  • W.L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Vascular Stents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Advancements in Drug-Eluting Stents
    • Growing Adoption of Bioabsorbable and Biodegradable Stents
    • Increasing Incidence of Coronary Artery Disease Driving Demand
    • Expansion of Stent Applications in Peripheral Artery Disease
    • Innovations in Stent Design for Improved Efficacy and Safety
    • Rising Demand for Minimally Invasive Vascular Procedures
    • Impact of Aging Population on Stent Market Growth
    • Focus on Reducing Restenosis Rates Post Stenting
    • Growing Use of Imaging-guided Stent Placement Techniques
    • Impact of Healthcare Reimbursement Policies on Stent Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Coronary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Peripheral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Evar Graft Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Evar Graft Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Evar Graft Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Vascular Stents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Balloon-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Balloon-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Balloon-Expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Self-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Self-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Self-Expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Vascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Vascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Vascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Vascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION